Survey on the Pharmacy Follow-up of Alli Purchasers

Survey on the Pharmacy Follow up of Alli Purchasers

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01387243

Enrollment

Registered

2011-07-04

Start date

2010-01-31

Completion date

2010-12-31

Last updated

2012-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Keywords

behavior modification, overweight, orlistat

Brief summary

To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.

Interventions

DRUGOrlistat

60 mg

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.

Design outcomes

Primary

Measure	Time frame
Change in Physical activity	baseline to 1 year

Secondary

Measure	Time frame
Change in dietary behavior	baseline to 1 year
Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)	baseline to 1 year
Satisfaction with management (i.e., results on weight and treatment comfort)	baseline to 1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026